BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21470373)

  • 1. Correlation of assessment of plasma cells by flow cytometry and detection of cytogenomic abnormalities by fluorescence in situ hybridization in plasma cell neoplasms.
    Lu G; Zhang XX; You MJ; Chen W
    Int J Lab Hematol; 2011 Oct; 33(5):545-50. PubMed ID: 21470373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of genomic abnormalities in multiple myeloma: the application of FISH analysis in combination with various plasma cell enrichment techniques.
    Hartmann L; Biggerstaff JS; Chapman DB; Scott JM; Johnson KR; Ghirardelli KM; Fritschle WK; Martinez DL; Bennington RK; de Baca ME; Wells DA; Loken MR; Zehentner BK
    Am J Clin Pathol; 2011 Nov; 136(5):712-20. PubMed ID: 22031309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma.
    Gomyo H; Shimoyama M; Minagawa K; Yakushijin K; Urahama N; Okamura A; Yamamoto K; Ito M; Chihara K; Hayashi Y; Matsui T
    Haematologica; 2003 Dec; 88(12):1358-65. PubMed ID: 14687988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates.
    Cogbill CH; Spears MD; Vantuinen P; Harrington AM; Olteanu H; Kroft SH
    Int J Lab Hematol; 2015 Dec; 37(6):797-808. PubMed ID: 26224420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.
    Tabernero D; San Miguel JF; Garcia-Sanz M; Nájera L; García-Isidoro M; Peréz-Simon JA; Gonzalez M; Wiegant J; Raap AK; Orfão A
    Am J Pathol; 1996 Jul; 149(1):153-61. PubMed ID: 8686739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interphase fluorescence in situ hybridization on selected plasma cells is superior in the detection of cytogenetic aberrations in plasma cell dyscrasia.
    Put N; Lemmens H; Wlodarska I; Konings P; Moreau Y; Hagemeijer A; Vandenberghe P; Michaux L
    Genes Chromosomes Cancer; 2010 Nov; 49(11):991-7. PubMed ID: 20662075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ancillary studies in the detection of residual disease in plasma cell myeloma in bone marrow.
    Zhao X; Huang Q; Slovak M; Weiss L
    Am J Clin Pathol; 2006 Jun; 125(6):895-904. PubMed ID: 16690489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.
    Slovak ML; Bedell V; Pagel K; Chang KL; Smith D; Somlo G
    Cancer Genet Cytogenet; 2005 Apr; 158(2):99-109. PubMed ID: 15796956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.
    Dong H; Yang HS; Jagannath S; Stephenson CF; Brenholz P; Mazumder A; Chari A
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):366-74. PubMed ID: 22658896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.
    Bacher U; Haferlach T; Kern W; Alpermann T; Schnittger S; Haferlach C
    Cancer Genet Cytogenet; 2010 Dec; 203(2):169-75. PubMed ID: 21156229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas.
    Palacio C; Acebedo G; Navarrete M; Ruiz-Marcellán C; Sanchez C; Blanco A; López A
    Haematologica; 2001 Sep; 86(9):934-40. PubMed ID: 11532621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma.
    Chandesris MO; Soulier J; Labaume S; Crinquette A; Repellini L; Chemin K; Malphettes M; Fieschi C; Asli B; Uzunhan Y; Fermand JP; Bories JC; Arnulf B
    Br J Haematol; 2007 Feb; 136(4):609-14. PubMed ID: 17223917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of 13q abnormalities in multiple myeloma using immunomagnetically selected plasma cells.
    Fiserová A; Hájek R; Holubová V; Büchler T; Sobotka J; Kovárová R; Musilová R; Bourková L; Buliková A; Mareschová I; Janácková Z; Váñová P; Kuglík P; Vorlícek J; Penka M
    Neoplasma; 2002; 49(5):300-6. PubMed ID: 12458327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cell enrichment enhances detection of high-risk cytogenomic abnormalities by fluorescence in situ hybridization and improves risk stratification of patients with plasma cell neoplasms.
    Lu G; Muddasani R; Orlowski RZ; Abruzzo LV; Qazilbash MH; You MJ; Wang Y; Zhao M; Chen S; Glitza IC; Medeiros LJ
    Arch Pathol Lab Med; 2013 May; 137(5):625-31. PubMed ID: 23627452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failed or inadequate bone marrow aspiration: a fast, simple and cost-effective method to produce a cell suspension from a core biopsy specimen.
    Novotny JR; Schmücker U; Staats B; Dührsen U
    Clin Lab Haematol; 2005 Feb; 27(1):33-40. PubMed ID: 15686505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.
    Huh HJ; Min HC; Cho HI; Chae SL; Lee DS
    Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry in the bone marrow staging of mature B-cell neoplasms.
    Stacchini A; Demurtas A; Godio L; Martini G; Antinoro V; Palestro G
    Cytometry B Clin Cytom; 2003 Jul; 54(1):10-8. PubMed ID: 12827663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of rhodamine 123 efflux by neoplastic plasma cells with clinical and biological characteristics of multiple myeloma.
    Pérez-Simón JA; Valverde B; Martínez A; Tabernero D; Almeida J; Gutierrez N; San Miguel JF; Orfao A
    Cytometry; 1999 Feb; 38(1):24-9. PubMed ID: 10088973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.